Related Experiment Video
Updated: Jul 6, 2026
11:24
Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy
Published on: October 18, 2011
14.7K
Radiation-Induced Cellular Plasticity: A Strategy for Combatting Glioblastoma
Ling He1,2, Daria Azizad3, Kruttika Bhat1
1Department of Radiation Oncology, David Geffen School of Medicine at UCLA.
Biorxiv : the Preprint Server for Biology
|May 27, 2024
Summary
This study shows that combining radiation with forskolin, a drug that activates adenyl cyclase, can reprogram deadly glioblastoma cells into less harmful types, improving survival in mice.
Area of Science:
- Neuro-oncology
- Cancer biology
- Cellular differentiation
Background:
- Glioblastoma is a fatal brain cancer with limited treatment options.
- Current therapies like surgery, chemotherapy, and radiotherapy offer only temporary disease control.
- Targeted therapies have not significantly improved glioblastoma patient survival.
Approach:
- Investigated the effect of combining radiation with forskolin, an adenyl cyclase activator, on glioma cells.
- Utilized a transient radiation-induced state of multipotency to alter cellular fate.
- Analyzed gene expression profiles and cell phenotypes using scRNAseq.
Key Points:
- Combined treatment induced neuronal markers and altered gene expression in glioma cells.
- scRNAseq revealed a shift towards microglia- and neuron-like phenotypes.
- The treatment reduced glioma stem cells and prolonged survival in mouse models.
Conclusions:
- Reprogramming glioma cells via differentiation therapy with forskolin and radiation shows promise.
- This combination strategy could potentially offer clinical benefits for glioblastoma patients.
- Further research into differentiation therapy for glioblastoma is warranted.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.